Daklinza
- Licence status
- Withdrawn: 30/08/2019
- Active substances
- Declatasvir dihydrochloride (bms-790052-05)
- Dosage Form
- Film-coated tablet
- Licence number
- EU/1/14/939/005-006
- Licence holder
- Bristol-Myers Squibb Pharma EEIG
Licence information
- ATC code
- J05AP07 Daclatasvir
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 24/06/2016